Alerts will be sent to your verified email
Verify EmailTATVA
Tatva Chintan Pharma
|
Paushak
|
Ultramar & Pigments
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
Total reactor capacity
|
500.0 kL | n/a | n/a |
Chemical Sector
|
|||
Capacity Utilization - Chemicals - Reactor
|
69.76 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
19.37 % | 14.0 % | 11.04 % |
5yr average Equity Multiplier
|
1.6 | 1.19 | 1.31 |
5yr Average Asset Turnover Ratio
|
0.74 | 0.46 | 0.56 |
5yr Avg Net Profit Margin
|
14.46 % | 25.72 % | 14.59 % |
Price to Book
|
2.24 | 2.88 | 1.16 |
P/E
|
115.51 | 23.08 | 18.19 |
5yr Avg Cash Conversion Cycle
|
136.22 Days | 3.28 Days | 31.89 Days |
Inventory Days
|
108.35 Days | 39.83 Days | 46.65 Days |
Days Receivable
|
71.34 Days | 91.28 Days | 33.34 Days |
Days Payable
|
79.58 Days | 124.62 Days | 57.93 Days |
5yr Average Interest Coverage Ratio
|
12.28 | 632.64 | 28.89 |
5yr Avg ROCE
|
21.27 % | 16.52 % | 12.71 % |
5yr Avg Operating Profit Margin
|
19.99 % | 33.92 % | 20.35 % |
5 yr average Debt to Equity
|
0.38 | 0.0 | 0.08 |
5yr CAGR Net Profit
|
-4.29 % | 9.26 % | -1.46 % |
5yr Average Return on Assets
|
11.17 % | 11.77 % | 8.47 % |
Shareholdings
|
|||
Promoter Holding
|
72.02 % | 67.13 % | 40.61 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-7.15 % | 0.16 % | -3.46 % |
Change in Mutual Fund Holding (3 Yrs)
|
-2.2 % | 0.0 | 0.0 |
Tatva Chintan Pharma
|
Paushak
|
Ultramar & Pigments
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|